Welcome Guest to Happi

Subscribe Free: Magazine | eNewsletter

current issue Wipes 2014
 •  P&G Gets No Charge from Batteries  •  Colgate Slumps in China, Brazil  •  Household, Personal Products Drive Sales at Unilever  •  P&G North America President to Retire  •  Glade Teams with Cirque du Soleil
Print

FDA Approves Marketing for Restylane Silk



Published June 17, 2014
Related Searches: officer fda gel chief
Post a comment

The US Food and Drug Administration (FDA) has issued marketing clearance for Valeant Pharmaceuticals' Restylane Silk Injectable Gel with 0.3% Lidocaine, a device indicated for submucosal implantation for lip augmentation and dermal implantation for correction of perioral rhytids in patients over the age of 21.

"We are pleased to have received marketing clearance from the FDA for Restylane Silk so quickly after the approval of Jublia," said J. Michael Pearson, chairman and chief executive officer. "Our R&D team is hitting on all cylinders and demonstrating that Valeant has a successful, output-focused R&D model that concentrates on areas of expertise where we are confident that our investments will pay off."



blog comments powered by Disqus